In a study by Baptiste et al., both drugs were used in non-obese women with PCOS, demonstrating that even in PCOS women who are not obese and have normal levels of insulin, hyperandrogenemia is connected with insulin resistance [6]. This evidence concerns the gene INS and polycystic ovary syndrome.